---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-125393"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:45:04.054690+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences Q3 revenue up 18% to $1.5M; net loss narrows to $1.6M

## Summary
- Total revenues $1.537M, +18% YoY; Zola coconut water revenue +55% YoY.
- Zola retail distribution expanded 68% vs Q3 2023.
- Net loss attributable to common stockholders $1.612M ($1.18/share) vs $2.567M ($1.89) in Q3 2023.
- Operating expenses increased 22% to $3.297M due to higher revenues and severance costs.
- Cash and cash equivalents $3.936M, down from $6.518M at Dec 31, 2023.

## SEC filing metadata
- accession: 0000950170-24-125393
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/0000950170-24-125393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/rkda-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-125393
- JSON: https://secwatch.observer/filing/0000950170-24-125393.json
- Plain text: https://secwatch.observer/filing/0000950170-24-125393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.